Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

triglyceride/obesidad

El enlace se guarda en el portapapeles.
Página 1 desde 100 resultados

Inhibitors of microsomal triglyceride transfer protein and apo-B secretion

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, particularly atherosclerosis and its

Inhibitors of microsomal triglyceride transfer protein and apo-B secretion

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, particularly atherosclerosis and its

Methods of treating of diabetes and obesity using FGF21 mutants

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
REFERENCE TO THE SEQUENCE LISTING The present application is being filed along with a Sequence Listing in electronic format. The Sequence Listing is provided as a file entitled A-1429-US-_DIV7_ST25.txt, created Dec. 19, 2013, which is 59 KB in size. The information in the electronic format of the
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2010/008944, filed Dec. 14, 2010, which claims benefit of Korean Patent Application No. 10-2010-0004901, filed Jan. 19, 2010. FIELD OF THE

Derivatives of amino acids for treatment of obesity and related disorders

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to novel amino acid derivatives, their stereoisomers, hydrates, and pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. BACKGROUND OF THE INVENTION Human obesity is a recognized health problem with
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of PCT International Application PCT/KR2011/010161, filed Dec. 27, 2011, which claims priority from Korean Patent Application 10-2011-0010585, filed Feb. 7, 2011. TECHNICAL FIELD The

Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/007905, filed Dec. 29, 2009, which claims benefit of Korean Patent Application 10-2009-0022937, filed Mar. 18, 2009. TECHNICAL FIELD The
TECHNICAL FIELD The present invention relates to a composition comprising the alcohol compound isolated from the extract of Cucurbitaceae family plant having anti-adipogenic and anti-obesity activity. BACKGROUND ART Adipogenesis is a process to differentiate preadipocytes into mature adipocytes and

Peptide inhibits blood triglyceride level

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to a novel peptide inhibiting elevations of triglyceride levels in blood; an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component; a food for specified health use (the so-called physiologically

Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to a novel peptide inhibiting elevations of triglyceride levels in blood; an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component; a food for specified health use (the so-called physiologically

Anti-obesity agent comprising compound containing benzotropolone ring

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
CROSS REFERENCE TO RELATED APPLICATIONS: This application is the National Stage of International Application No. PCT/JP2010/058624, filed May 21, 2010, and claims benefit of Japanese Application No. 2009-123585 filed May 21, 2009, which are herein incorporated by reference in their

Anti-obesity agent comprising compound containing benzotropolone ring

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to an anti-obesity agent containing a benzotropolone ring-containing compound. BACKGROUND ART Obesity is one of the most significant diseases in modern society and the main factor of obesity is excessive intake of fat. Excessive intake of fat is known to

Alcohol-fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION (a) Field of the Invention The present invention relates to an extract of mixed herb medicine, and a pharmaceutical composition for the prevention and the treatment of obesity containing the extract as an effective ingredient or health food containing the same, more

Oxadiazole benzenesulfonamides as selective .beta..sub.3 Agonist for the treatment of Diabetes and Obesity

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION .beta.-Adrenoceptors have been subclassified as .beta..sub.1 and .beta..sub.2 since 1967. Increased heart rate is the primary consequence of .beta..sub.1 -receptor stimulation, while bronchodilation and smooth muscle relaxation typically result from .beta..sub.2

Substituted sulfonamides as selective .beta..sub.3 agonists for the treatment of diabetes and obesity

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION .beta.-Adrenoceptors have been subclassified as .beta..sub.1 and .beta..sub.2 since 1967. Increased heart rate is the primary consequence of .beta..sub.1 -receptor stimulation, while bronchodilation and smooth muscle relaxation typically result from .beta..sub.2
Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge